Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

LAG3 ELISA Kit

LAG3 Reactivity: Mouse Colorimetric Sandwich ELISA 0.156 ng/mL - 10 ng/mL Cell Lysate, Tissue Homogenate
Catalog No. ABIN6213395
  • Target See all LAG3 ELISA Kits
    LAG3 (Lymphocyte-Activation Gene 3 (LAG3))
    Reactivity
    • 4
    • 3
    • 1
    Mouse
    Detection Method
    Colorimetric
    Method Type
    Sandwich ELISA
    Detection Range
    0.156 ng/mL - 10 ng/mL
    Minimum Detection Limit
    0.156 ng/mL
    Application
    ELISA
    Purpose
    Lymphocyte Activation Gene 3 ELISA Kit is an ELISA Kit against Lymphocyte Activation Gene 3.
    Sample Type
    Cell Lysate, Tissue Homogenate
    Analytical Method
    Quantitative
    Sensitivity
    < 0.058 ng/mL
    Featured
    Discover our best selling LAG3 ELISA Kit
    Top Product
    Discover our top product LAG3 ELISA Kit
  • Application Notes

    Stability: The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5 % within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.

    Recommended dilutions: Optimal dilutions/concentrations should be determined by the end user.

    Standard Form: Lyophilized

    Plate
    Pre-coated
    Restrictions
    For Research Use only
  • Storage
    4 °C/-20 °C
    Storage Comment
    Upon receipt, store the kit according to the storage instruction in the kit's manual.
    Expiry Date
    6 months
  • Target See all LAG3 ELISA Kits
    LAG3 (Lymphocyte-Activation Gene 3 (LAG3))
    Alternative Name
    Lymphocyte Activation Gene 3 (LAG3 Products)
    Synonyms
    CD223 ELISA Kit, LAG-3 ELISA Kit, Ly66 ELISA Kit, lymphocyte activating 3 ELISA Kit, lymphocyte-activation gene 3 ELISA Kit, LAG3 ELISA Kit, Lag3 ELISA Kit
    Pathways
    Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
You are here:
Support